SCHEMBL6502203

SCHEMBL6502203

CCOC(=O)CN(C)CCCNC(=O)/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OC

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.60
ERBB2 P04626 7/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1417841 1.00 EGFR (0.60) EGFRERBB2
SCHEMBL6505388 0.96 EGFR (0.58) EGFRERBB2
SCHEMBL6505387 0.96 EGFR (0.58) EGFRERBB2
SCHEMBL1417848 0.95 EGFR (0.59) EGFRERBB2
SCHEMBL1417850 0.95 EGFR (0.59) EGFRERBB2
SCHEMBL1417899 0.94 EGFR (0.63) EGFRERBB2
SCHEMBL1417896 0.94 EGFR (0.63) EGFRERBB2
SCHEMBL1418619 0.91 EGFR (0.57) EGFRERBB2
SCHEMBL1418621 0.91 EGFR (0.57) EGFRERBB2
SCHEMBL1417878 0.90 EGFR (0.58) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6972288-B1 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-12-06 US disclosed